News & Financial Highlights


The DNA Revolution
The DNA Revolution
Fifty Years after Watson and Crick, the New Questions in Genetics - From NPR

CEO 2003
BioWorld Reports from BIO's CEO Conference
Deal-Making Rules Changing Deal-Making Rules Changing; Pharma, Biotechs Shop Around
FDA Chief Outlines Strategy FDA Chief Outlines Strategy; Industry Still 'Upbeat, Tough'

More Features >

Resources
BIO: Guide to Biotechnology
Highlight: Beyond Borders: The Global Biotechnology Report 2003
Beyond Borders: The Global Biotechnology Report 2002
Beyond Borders covers Europe, the Americas, and the Asia/Pacific region offering insight into the performance of more than 600 publicly traded and 4,200 privately held companies.
More Resources >

Integrating Intellectual Property Rights and Development Policy
Report Monitor
Childhood Vaccines: Challenges in Preventing Future Shortages
Integrating Intellectual Property Rights and Development Policy
More Reports >
NASDAQ
NASDAQ Biotechnology Index

799.98 up 8.67
Information delayed 15 minutes.
Details (NASDAQ.com) >
vital signs
A Consistent Record of Growth
November Vital Signs >